Reduced anxious behavior in mice lacking the CCK2 receptor gene

被引:26
作者
Horinouchi, Y
Akiyoshi, J
Nagata, A
Matsushita, H
Tsutsumi, T
Isogawa, K
Noda, T
Nagayama, H
机构
[1] Oita Med Univ, Dept Neuropsychiat, Oita 8795593, Japan
[2] Kobe Univ, Sch Med, Dept Med, Div 3, Kobe, Hyogo 650, Japan
[3] Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan
关键词
anxiety; behavior; cholecystokinin; receptor;
D O I
10.1016/S0924-977X(03)00103-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cholecystokinin 2 (CCK2) receptors have been implicated as mediators of anxiety in standard mouse models such as exploratory behavior both in black and white test boxes and in elevated plus-mazes. We investigated the role of the CCK2 receptor in anxiety by evaluating the behavior of mice lacking the gene for this receptor in these standard anxiety models (i.e., exploratory behavior in a black and white test box and exploratory behavior in an elevated plus-maze). In the black and white test box, mice lacking the CCK2 receptor gene showed significantly increased numbers of transitions between the boxes compared to control mice. In the elevated plus-maze, mice lacking the CCK2 receptor gene displayed significantly more head dips than control mice. These results suggest that mice lacking the CCK2 receptor gene are less anxious than normal mice. (C) 2003 Elsevier B.V./ECNP. All rights reserved.
引用
收藏
页码:157 / 161
页数:5
相关论文
共 29 条
[1]   Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia [J].
Akiyoshi, J ;
Isogawa, K ;
Tsutsumi, T ;
Kasturagi, S ;
Kohno, K ;
Furuta, M ;
Yamamoto, Y ;
Yamada, K ;
Fujii, I .
BIOLOGICAL PSYCHIATRY, 1997, 42 (02) :151-154
[2]  
Akiyoshi J, 1996, J NEUROCHEM, V66, P1610
[3]  
Bourin M, 1996, ENCEPHALE, V22, P35
[4]  
BRADWEJN J, 1991, ARCH GEN PSYCHIAT, V48, P603
[5]  
BRADWEJN J, 1994, ARCH GEN PSYCHIAT, V51, P486
[6]  
Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.3.CO
[7]  
2-4
[8]  
CORWIN RL, 1995, J NEUROCHEM, V65, P208
[9]   ANXIOLYTIC EFFECTS OF CCK-B ANTAGONISTS [J].
COSTALL, B ;
DOMENEY, AM ;
HUGHES, J ;
KELLY, ME ;
NAYLOR, RJ ;
WOODRUFF, GN .
NEUROPEPTIDES, 1991, 19 :65-73
[10]   Behavioral profile of CCK2 receptor-deficient mice [J].
Daugé, V ;
Sebret, A ;
Beslot, F ;
Matsui, T ;
Roques, BP .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (05) :690-698